Home › Transthyretin-Related Hereditary Amyloidosis › California › Los Angeles
Transthyretin-Related Hereditary Amyloidosis clinical trials in Los Angeles, CA
5 studies for Transthyretin-Related Hereditary Amyloidosis are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RecruitingObservational study
- Research Site, Los Angeles
Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
RecruitingObservational study
- Research Site, Los Angeles
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
RecruitingObservational study
- Clinical Trial Site, Los Angeles
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RecruitingPhase 3
- Cedars-Sinai Medical Center, Los Angeles
- Western Greater Los Angeles VA Medical Center, Los Angeles
Transthyretin-Related Hereditary Amyloidosis trials in other cities
- New York City, NY5 studies
- Durham, NC4 studies
- Philadelphia, PA4 studies
- Baltimore, MD4 studies
- Portland, OR4 studies
- San Diego, CA4 studies
- Boston, MA4 studies
- Dallas, TX4 studies
- St. Louis, MO3 studies
- Kansas City, MO3 studies
- Washington, DC3 studies
- Houston, TX3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.